Found 386 matching trials
A Study to Evaluate the Safety of Concurrent Durvalumab With CRT Followed by Durvalumab for Chinese Unresectable Stage III NSCLC PHASE2 This is a prospective, multi-center, single arm study assessing the efficac...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Brief Contextual-Behavioral vs Twelve-Step Intervention for Emotion Regulation in Substance Use: Pilot Study NA This study evaluated the effectiveness of a brief behavioral-contextual int...
Show More Location
Comunidad Terapéutica Under The Tree
Learn More & Join Trial
Use of Thalidomide, Lenalidomide, Carfilzomib, Bortezomib and Vorinostat in the Initial Treatment of Newly Diagnosed Multiple Myeloma Patients PHASE3 The purpose of this study is to compare a standard chemotherapy regimen of ...
Show More Location
112 sites UK wide
Treatments Being Tested
Induction (intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone (CRD) regimen Induction (intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone (CTD) regimen Induction (intensive pathway) - carfilzomib, cyclophosphamide, lenalidomide, & dexamethasone (CCRD) regimen Induction (non-intensive pathway) - cyclophosphamide, lenalidomide, & dexamethasone attenuated (CRDa) regimen Induction (non-intensive pathway) - cyclophosphamide, thalidomide, & dexamethasone attenuated (CTDa) regimen Consolidation (intensive & non-intensive pathways) - bortezomib, cyclophosphamide, & dexamethasone (VCD) regimen Maintenance (intensive & non-intensive pathways) - lenalidomide maintenance Maintenance (intensive & non-intensive pathways - protocol v5.0 only) - lenalidomide plus vorinostat maintenance High dose melphalan therapy and autologous stem cell transplant (intensive pathway only) Learn More & Join Trial
KORTUC (KRC-01) Plus Radiotherapy for Organ Preservation in Rectal Cancer PHASE2 This phase II clinical trial is evaluating whether adding KRC-01 injections...
Show More Learn More & Join Trial
Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC PHASE2 This study is being done to learn more about a new medicine called PF-08634...
Show More Location
Clearview Cancer Institute (Crestwood)
Learn More & Join Trial
Comparison of Two Combination Chemotherapy Regimens With Either Vincristine or Vinblastine in Treating Patients With Advanced Anaplastic Large Cell Lymphoma PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Lurleen Wallace Comprehensive Cancer at University of Alabama - Birmingham
Learn More & Join Trial
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML PHASE3 MRD driven study. Addition of gemtuzumab to conventional chemotherapy to re...
Show More Location
A.O. - SS. Antonio e Biagio e Cesare Arrigo - SC Ematologia
Learn More & Join Trial
Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer N/A This is a multicenter, randomized, controlled phase III trial to evaluate t...
Show More Location
Department of Radiation Oncology, Shandong Cancer Hospital and Institute
Learn More & Join Trial
Discontinuation of Hypomethylating Agent and Venetoclax in Patients With AML MRD PHASE2 The purpose of this research study is to see if people whose Acute myeloid ...
Show More Location
Moffitt Cancer Center
Learn More & Join Trial
Clofarabine or High-Dose Cytarabine and Pegaspargase in Children with ALL PHASE2 RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Show More Location
Krankenanstalten Gilead gCmbH Neurochirurgische Klinik
Learn More & Join Trial